[Contribution of Japan to develop new anticancer agents].
作者信息
Sajjo N
机构信息
Pharmacology Division, National Cancer Center Research Institute, Japan.
出版信息
Gan To Kagaku Ryoho. 1996 Jan;23(2):242-6.
PMID:8611054
Abstract
Many drugs developed in Japan have been started their clinical trials in USA and European countries. The clinical trials in Japan will be requested the strict standard in accordance with the introduction of ICH-GCP. It is strongly requested for the medical student to be educated on the importance and methodology of clinical trials at university.
摘要
Zotero 插件